ClinicalTrials.Veeva

Menu

The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE

University of Miami logo

University of Miami

Status

Enrolling

Conditions

Airway Obstruction

Treatments

Device: Nasal Cannula
Device: McMurray Enhanced Airway

Study type

Interventional

Funder types

Other

Identifiers

NCT05974488
20221246

Details and patient eligibility

About

The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > or = 18 years old
  • Patients willing to participate and provide an informed consent
  • Patients scheduled to undergo an elective TEE procedure.

Exclusion criteria

  • Patients with history of uncontrolled gastroesophageal reflux disease
  • Patients with anatomical airway obstruction
  • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Distal Pharyngeal Airway
Experimental group
Description:
Participants in this group will use the McMurray enhanced airway to have oxygen delivered throughout a TEE procedure for up to 60 minutes.
Treatment:
Device: McMurray Enhanced Airway
Nasal cannula group
Active Comparator group
Description:
Participant in this group will receive oxygen through a nasal cannula during the TEE procedure for up to 60 minutes.
Treatment:
Device: Nasal Cannula

Trial contacts and locations

1

Loading...

Central trial contact

Fouad G Souki, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems